Viewing data from:

FINASTERIDE

ANDA

FINASTERIDE | A090060 | HETERO LABS LTD UNIT III

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: PROPECIA(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 4 NDCs

Highest NADAC/Unit

$0.0419

per ea

Lowest NADAC/Unit

$0.0419

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
31722052630FINASTERIDE 1 MG TABLET	$0.0419	EA	Generic	—	2026-06-17
31722052690FINASTERIDE 1 MG TABLET	$0.0419	EA	Generic	—	2026-06-17
43598039030FINASTERIDE 1 MG TABLET	$0.0419	EA	Generic	—	2026-06-17
43598039090FINASTERIDE 1 MG TABLET	$0.0419	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain9 active DMFs5 inactive

8 active API suppliers hold Drug Master Files for this ingredient.

CIPLA LTDFINASTERIDE USP

DMF 157782001

DR REDDYS LABORATORIES LTDFINASTERIDE USP (FORM III)

DMF 160102002

STERLING SPAFINASTERIDE

DMF 184832005

APITORIA PHARMA PRIVATE LTDFINASTERIDE USP

DMF 193082006

HETERO LABS LTDFINASTERIDE

DMF 208932007

MSN LABORATORIES PRIVATE LTDFINASTERIDE USP

DMF 212762008

SUN PHARMACEUTICAL INDUSTRIES LTDFINASTERIDE USP

DMF 213002008

HUBEI GEDIAN HUMANWELL PHARMACEUTICAL CO LTDFINASTERIDE

DMF 250562011

DR REDDYS LABORATORIES LTDFINASTERIDE - USP (FORM-I)

DMF 437322026

GEDEON RICHTER PLCInactiveFINASTERIDE USP

DMF 175752004

CIPLA LTDInactiveFINASTERIDE USP

DMF 176802004

CRYSTAL PHARMA SAUInactiveFINASTERIDE

DMF 185512005

DR REDDYS LABORATORIES LTDInactiveFINASTERIDE (FORM I)

DMF 205212007

YUAN XINYANInactiveFINASTERIDE (API)

DMF 226752009

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 1MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Jul 1, 2013

No patent or exclusivity listings for this strength.